tradingkey.logo

Anbio Biotechnology

NNNN
詳細チャートを表示
25.650USD
+1.590+6.61%
終値 02/06, 16:00ET15分遅れの株価
1.13B時価総額
416.53直近12ヶ月PER

Anbio Biotechnology

25.650
+1.590+6.61%
Intraday
1m
30m
1h
D
W
M
D

本日

+6.61%

5日間

+17.07%

1ヶ月

-20.07%

6ヶ月

-42.42%

年初来

-14.70%

1年間

0.00%

詳細チャートを表示

TradingKey 株式スコア

データが不十分なため、株式スコアは利用できません。

Anbio Biotechnology ニュース

最新情報をお待ちください...

財務指標

EPS

会社から関連データがまだ開示されていません。

総売上高

会社から関連データがまだ開示されていません。

Anbio Biotechnologyの企業情報

Anbio Biotechnology is a Germany-based medical device company. The Company is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products offer solutions for over the counter (OTC) use, point-of-care (POCT) settings, and laboratory applications, ensuring that both healthcare providers and patients have access to reliable and efficient diagnostic tools in any setting. Its IVD products detect a wide range of biomarkers across critical medical fields, including infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Some of its IVD platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR) and Loop-mediated Isothermal Amplification (LAMP).
企業コードNNNN
企業名Anbio Biotechnology
最高経営責任者「CEO」Lau (Michael)
ウェブサイトhttps://anbiobiotechnology.com/
KeyAI